期刊文献+

补肾活血中药对椎体成形术后患者的视觉模拟评分及骨密度的影响 被引量:10

Effect of Chinese Medicine for Reinforcing Kidney and Activating Blood on Visual Analogue Scale and Bone Density in Patients of Post Vertebroplasty
下载PDF
导出
摘要 目的:观察补肾活血中药对椎体成形术(PVP)后患者临床症状改善的促进作用。方法:选择确诊为骨质疏松性椎体压缩性骨折的96例患者,均采用标准的PVP手术,根据患者术后是否服用补肾活血中药将其分为:A组48例为治疗组(口服补肾活血中药+钙剂);B组48例为对照组(口服钙剂)。分别于术后3个月、6个月、12个月应用视觉模拟评分(VAS)和骨密度来评价患者疼痛改善及骨质改变情况。结果:所有患者均顺利完成手术,术后患者疼痛均得到迅速缓解。术后3个月、6个月和12个月两组患者VAS评分、骨密度均较术前有明显改善(P<0.05)。组间比较发现,术后3个月时VAS评分、骨密度差异无显著性(P>0.05);但术后6个月及术后12个月时两组间VAS评分、ODI评分比较差异有显著性(P<0.05)。结论:PVP是治疗骨质疏松性椎体压缩骨折的有效方法,同时,术后口服补肾活血中药可对患者的疼痛缓解和骨质改善起促进作用,随着用药时间的延长,作用越明显。 Objective:to observe the promotive effect of Chinese medicine for reinforcing kidney and activating blood on patients of post PVP.Methods:94 patients with osteoporosis-induced compression fracture of vertebral body , after standard PVP, were divided, according to whether they took medicine , into two groups , group A ( treatment group taking orally the medicine and calcium ) and group B ( control group taking calcium ) .Visual analogue scale ( VAS) and bone density were used to evaluate the pain improvement and sclerotin changes respectively 3, 6 and 12 months after operation.Results:All the patients were operated on smoothly and the pains were quickly relieved.All the tested indexes were improved significantly ( P 〈0.05) .Comparisons between groups showed that there was on significant difference about VAS and bone density 3 months after operation ( P 〉0.05 ) , but there were significant difference a-bout VAS and ODI 6 and 12 months after operation ( P 〈0.05) .Conclusion:PVP is an effective way in curing osteoporosis-induced compression fracture of vertebral body and meanwhile Chinese medicine for reinforcing kidney and activating blood can relieve pain and improve the sclerotin.The longer the medication is , the more obvious the action will be.
出处 《河北中医药学报》 2013年第4期6-8,共3页 Journal of Hebei Traditional Chinese Medicine and Pharmacology
基金 河北省中医药管理局资助项目:No 2012024
关键词 补肾活血中药 骨质疏松 骨密度 椎体成形术 骨痹 Chinese medicine for reinforcing kidney and activating blood osteoporosis bone density percutaneous vertebro plasty (PVP) heumatism
  • 相关文献

参考文献4

二级参考文献30

  • 1焦昌明,禹红,石芳,柯贤柱.经皮椎体成形术联合唑来磷酸治疗椎体转移性肿瘤[J].生物骨科材料与临床研究,2012,9(3):60-61. 被引量:6
  • 2杨惠林,牛国旗,王根林,陈亮,陆俭,赵刘军,顾晓晖,唐天驷.椎体后凸成形术治疗周壁破损的骨质疏松性椎体骨折[J].中华骨科杂志,2006,26(3):165-169. 被引量:94
  • 3Genant HK,Cooper C,Poor G,et al.Interim report and recommendations of the World Health Organization Task Force for osteoporosis[J].Osteoporos Int,1999,10(4):259-264.
  • 4Lin WC,Lee YC,Lee CH,et al.Refractures in cemented vertebrae after percutaneous vertebroplasty:a retrospective analysis[J].Eur Spine,2008,17(4):592-599.
  • 5Tseng YY,Yang TC,Tu PH,et al.Repeated and multiple new vertebral compression fractures after percutaneous transpedicu lar vertebroplasty[J].Spine,2009,34(18):1917-1922.
  • 6Ross PD,Genant HK,Davis JW,et al.Predicting vertebral fracture incidence from prevalent fractures and bone density among nonblack,osteoporotic women[J].Osteoporos Int,1993,3(3):120-126.
  • 7Melton LJ.Perspective:how many women have osteoporosis now[J].J Bone Miner Res,1995,10(2):175-177.
  • 8Lindsay R,Silverman SL,Cooper C,et al.Risk of new vertebral fracture in the year following a fracture[J].JAMA,2001,285(3):320-323.
  • 9Komemushi A,Tanigawa N,Kariya S,et al.Percutaneous vertebroplasty for osteoporotic compression fracture:multivariate study of predictors of new vertebral body fracture[J].Cardiovasc Intervent Radiol,2006,29(4):580-585.
  • 10Lo YP,Chen WJ,Chen LH,et al.New vertebral fracture after vertebroplasty[J].Trauma,2008,65(6):1439-1445.

共引文献109

同被引文献95

引证文献10

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部